What is ZoomRx?
ZoomRx operates as a privately-held consultancy specializing in primary and syndicated market research within various therapeutic specialties. The firm is dedicated to providing richer insights and higher return on investment for its pharmaceutical and biotech clientele through innovative research methodologies and cutting-edge technology. A key component of its offering is a feature-rich mobile technology platform, specifically customized for the healthcare industry, capable of generating both quantitative and qualitative data. Headquartered in Cambridge, MA, with an additional office in Chennai, India, ZoomRx leverages its technological prowess to enhance market understanding for its clients.
How much funding has ZoomRx raised?
ZoomRx has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in ZoomRx
PPP
Public-Private Partnership
What's next for ZoomRx?
The recent major strategic investment, coupled with the overall large-scale late-stage funding context, suggests ZoomRx is poised for significant operational expansion and market penetration. This capital infusion is likely to fuel further development of its proprietary technology platform, enhance its research capabilities, and broaden its client base within the pharmaceutical and biotechnology industries. ZoomRx's focus on delivering actionable insights through advanced analytics positions it for continued growth and leadership in the healthcare market intelligence space.
See full ZoomRx company page
